SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Gold/Mining/Energy : Nuvo Research Inc -- Ignore unavailable to you. Want to Upgrade?

To: Joe Krupa who wrote (8195)12/8/2001 1:43:34 PM
From: Mark Bartlett  Respond to of 14101
 
Joe,

<<That's why I suggested that yesterday's price move for Provalis was part of the completion of a technical move up (pennant), that commenced with the FDA approval of the glycosal testing device. >>

If I recall correctly, Provalis' sales for their glycosal testing apparatus were not that good previous to FDA approval. Lets hope the same pattern plays out with Pennsaid and DMX.

MB



To: Joe Krupa who wrote (8195)12/8/2001 4:44:36 PM
From: jef saunders  Read Replies (1) | Respond to of 14101
 
> Would be nice though if there was some Pennsaid fuel in there too!

from previous recent posts, it sounds like Pennsaid sales in England suck.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News